-
1
-
-
69149105448
-
Guidelines for pathologic diagnosis of malignant mesothelioma: A consensus statement from the International Mesothelioma Interest Group
-
A.N. Husain, T.V. Colby, and N.G. Ordóñez Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group Arch Pathol Lab Med 133 2009 1317 1331
-
(2009)
Arch Pathol Lab Med
, vol.133
, pp. 1317-1331
-
-
Husain, A.N.1
Colby, T.V.2
Ordóñez, N.G.3
-
2
-
-
79955696363
-
Diffuse malignant peritoneal mesothelioma: Systematic review of clinical management and biological research
-
D. Baratti, S. Kusamura, and M. Deraco Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research J Surg Oncol 103 2011 822 831
-
(2011)
J Surg Oncol
, vol.103
, pp. 822-831
-
-
Baratti, D.1
Kusamura, S.2
Deraco, M.3
-
3
-
-
77951893959
-
Malignant peritoneal mesothelioma: A multicenter study on 81 cases
-
V. de Pangher Manzini, L. Recchia, and M. Cafferata Malignant peritoneal mesothelioma: a multicenter study on 81 cases Ann Oncol 21 2010 348 353
-
(2010)
Ann Oncol
, vol.21
, pp. 348-353
-
-
De Pangher Manzini, V.1
Recchia, L.2
Cafferata, M.3
-
4
-
-
63449105164
-
Malignant peritoneal mesothelioma - Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent
-
G. Carteni, C. Manegold, and G.M. Garcia Malignant peritoneal mesothelioma - results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent Lung Cancer 64 2009 211 218
-
(2009)
Lung Cancer
, vol.64
, pp. 211-218
-
-
Carteni, G.1
Manegold, C.2
Garcia, G.M.3
-
5
-
-
49049097151
-
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: Final report of a phase II trial
-
G.R. Simon, C.F. Verschraegen, and P.A. Jänne Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial J Clin Oncol 26 2008 3567 3572
-
(2008)
J Clin Oncol
, vol.26
, pp. 3567-3572
-
-
Simon, G.R.1
Verschraegen, C.F.2
Jänne, P.A.3
-
6
-
-
1542648318
-
Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy
-
A.L. Feldman, S.K. Libutti, and J.F. Pingpank Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy J Clin Oncol 21 2003 4560 4567
-
(2003)
J Clin Oncol
, vol.21
, pp. 4560-4567
-
-
Feldman, A.L.1
Libutti, S.K.2
Pingpank, J.F.3
-
7
-
-
33845631273
-
Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma
-
T.D. Yan, E.A. Brun, and C.A. Cerruto Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma Ann Surg Oncol 14 2007 41 49
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 41-49
-
-
Yan, T.D.1
Brun, E.A.2
Cerruto, C.A.3
-
8
-
-
37149047839
-
Malignant peritoneal mesothelioma: Treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy
-
D. Elias, V. Bedard, and T. Bouzid Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy Gastroenterol Clin Biol 31 2007 784 788
-
(2007)
Gastroenterol Clin Biol
, vol.31
, pp. 784-788
-
-
Elias, D.1
Bedard, V.2
Bouzid, T.3
-
9
-
-
74949123203
-
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: Multi-institutional experience
-
T.D. Yan, M. Deraco, and D. Baratti Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience J Clin Oncol 27 2009 6237 6242
-
(2009)
J Clin Oncol
, vol.27
, pp. 6237-6242
-
-
Yan, T.D.1
Deraco, M.2
Baratti, D.3
-
10
-
-
74649083292
-
Lymph node metastases in diffuse malignant peritoneal mesothelioma
-
D. Baratti, S. Kusamura, and A.D. Cabras Lymph node metastases in diffuse malignant peritoneal mesothelioma Ann Surg Oncol 17 2010 45 53
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 45-53
-
-
Baratti, D.1
Kusamura, S.2
Cabras, A.D.3
-
11
-
-
78049463296
-
Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: Mitomycin versus cisplatin
-
A.U. Blackham, P. Shen, and J.H. Stewart Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin Ann Surg Oncol 17 2010 2720 2727
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 2720-2727
-
-
Blackham, A.U.1
Shen, P.2
Stewart, J.H.3
-
12
-
-
0028797043
-
Peritonectomy procedures
-
P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1995 29 42
-
(1995)
Ann Surg
, vol.221
, pp. 29-42
-
-
Sugarbaker, P.H.1
-
13
-
-
0025020584
-
Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment
-
G. Los, P.H. Mutsaers, and W.J. Lenglet Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment Cancer Chemother Pharmacol 25 1990 389 394
-
(1990)
Cancer Chemother Pharmacol
, vol.25
, pp. 389-394
-
-
Los, G.1
Mutsaers, P.H.2
Lenglet, W.J.3
-
14
-
-
27644476267
-
Diffuse malignant mesothelioma of the peritoneum
-
D. Nonaka, S. Kusamura, and D. Baratti Diffuse malignant mesothelioma of the peritoneum Cancer 104 2005 2181 2188
-
(2005)
Cancer
, vol.104
, pp. 2181-2188
-
-
Nonaka, D.1
Kusamura, S.2
Baratti, D.3
-
15
-
-
0029914456
-
Current methodologies for clinical assessment of patients with peritoneal carcinomatosis
-
P. Jaquet, and P.H. Sugarbaker Current methodologies for clinical assessment of patients with peritoneal carcinomatosis J Exp Clin Cancer Res 15 1996 49 58
-
(1996)
J Exp Clin Cancer Res
, vol.15
, pp. 49-58
-
-
Jaquet, P.1
Sugarbaker, P.H.2
-
16
-
-
31544444216
-
Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion
-
M. Deraco, D. Nonaka, and D. Baratti Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion Ann Surg Oncol 13 2006 229 237
-
(2006)
Ann Surg Oncol
, vol.13
, pp. 229-237
-
-
Deraco, M.1
Nonaka, D.2
Baratti, D.3
-
17
-
-
84862564957
-
Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: A controlled study
-
[epub ahead of print]
-
D. Baratti, S. Kusamura, A.D. Cabras, and M. Deraco Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study Ann Surg Oncol 2012 [epub ahead of print]
-
(2012)
Ann Surg Oncol
-
-
Baratti, D.1
Kusamura, S.2
Cabras, A.D.3
Deraco, M.4
-
18
-
-
0037080101
-
Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: Phase i study
-
C.R. Rossi, M. Foletto, and S. Mocellin Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study Cancer 94 2002 492 499
-
(2002)
Cancer
, vol.94
, pp. 492-499
-
-
Rossi, C.R.1
Foletto, M.2
Mocellin, S.3
-
19
-
-
75049085762
-
Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma
-
T.C. Chua, P. Yao, and J. Akther Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma Pathol Oncol Res 15 2009 671 678
-
(2009)
Pathol Oncol Res
, vol.15
, pp. 671-678
-
-
Chua, T.C.1
Yao, P.2
Akther, J.3
-
20
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
-
21
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Soc 53 1958 457 481
-
(1958)
J Am Stat Soc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
22
-
-
0000336139
-
Regression models and life tables (with discussion)
-
D.R. Cox Regression models and life tables (with discussion) J R Stat Soc B 34 1972 187 220
-
(1972)
J R Stat Soc B
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
23
-
-
77956255022
-
Continued uncertainty regarding hyperthermic intraperitoneal chemotherapy in malignant peritoneal mesothelioma
-
M. Markman Continued uncertainty regarding hyperthermic intraperitoneal chemotherapy in malignant peritoneal mesothelioma J Clin Oncol 28 2010 e418
-
(2010)
J Clin Oncol
, vol.28
, pp. 418
-
-
Markman, M.1
-
24
-
-
84855830266
-
Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies
-
S. Kusamura, D. Baratti, and M. Deraco Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies Ann Surg 255 2012 348 356
-
(2012)
Ann Surg
, vol.255
, pp. 348-356
-
-
Kusamura, S.1
Baratti, D.2
Deraco, M.3
-
25
-
-
36248989049
-
Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma
-
N. Zaffaroni, A. Costa, and M. Pennati Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma Cell Oncol 29 2007 453 466
-
(2007)
Cell Oncol
, vol.29
, pp. 453-466
-
-
Zaffaroni, N.1
Costa, A.2
Pennati, M.3
-
26
-
-
18244362080
-
P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma
-
A.C. Borczuk, R.N. Taub, and M. Hesdorffer P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma Clin Cancer Res 11 2005 3303 3308
-
(2005)
Clin Cancer Res
, vol.11
, pp. 3303-3308
-
-
Borczuk, A.C.1
Taub, R.N.2
Hesdorffer, M.3
-
27
-
-
33646151164
-
Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation
-
K.L. Dumoff, C.S. Chu, and E.E. Harris Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation Mod Pathol 19 2006 708 716
-
(2006)
Mod Pathol
, vol.19
, pp. 708-716
-
-
Dumoff, K.L.1
Chu, C.S.2
Harris, E.E.3
-
28
-
-
59249105807
-
Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies
-
T. Ito, G. Ishii, and K. Nagai Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies Lung Cancer 63 2009 418 424
-
(2009)
Lung Cancer
, vol.63
, pp. 418-424
-
-
Ito, T.1
Ishii, G.2
Nagai, K.3
-
29
-
-
77950547974
-
Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas
-
J.P. Rodrigo, D. García-Carracedo, and M.V. González Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas Mol Cancer 9 2010 48
-
(2010)
Mol Cancer
, vol.9
, pp. 48
-
-
Rodrigo, J.P.1
García-Carracedo, D.2
González, M.V.3
-
30
-
-
84855357168
-
Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients
-
Y.K. Chao, W.Y. Chuang, and C.J. Yeh Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients J Surg Oncol 105 2012 183 188
-
(2012)
J Surg Oncol
, vol.105
, pp. 183-188
-
-
Chao, Y.K.1
Chuang, W.Y.2
Yeh, C.J.3
-
31
-
-
58549113827
-
Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma
-
J.M. Foster, Z. Gatalica, and S. Lilleberg Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma Ann Surg Oncol 16 2009 152 158
-
(2009)
Ann Surg Oncol
, vol.16
, pp. 152-158
-
-
Foster, J.M.1
Gatalica, Z.2
Lilleberg, S.3
-
32
-
-
77957203611
-
Receptor tyrosine kinase and downstream signaling analysis in diffuse malignant peritoneal mesothelioma
-
F. Perrone, G. Jocollè, and M. Pennati Receptor tyrosine kinase and downstream signaling analysis in diffuse malignant peritoneal mesothelioma Eur J Cancer 46 2010 2837 2848
-
(2010)
Eur J Cancer
, vol.46
, pp. 2837-2848
-
-
Perrone, F.1
Jocollè, G.2
Pennati, M.3
|